May 12, 2026 05:06PM
Apr 15, 2026 04:05PM
Apr 7, 2026 08:08AM
Mar 31, 2026 04:27AM
Mar 30, 2026 03:41PM
Mar 16, 2026 11:22AM
Mar 13, 2026 08:06AM Savara submits BLA for MOLBREEVI with FDA priority review set for August
Mar 6, 2026 04:05PM
Feb 23, 2026 04:58AM
Feb 20, 2026 04:15PM
Jan 27, 2026 08:06AM
Dec 23, 2025 06:46AM
Dec 23, 2025 06:42AM
Dec 22, 2025 08:31AM Savara resubmits drug application to FDA with new manufacturer
Dec 11, 2025 08:05AM
Dec 8, 2025 07:32AM
Dec 2, 2025 08:06AM
Nov 13, 2025 06:36AM
Nov 13, 2025 04:15AM
Oct 29, 2025 04:01PM
Oct 23, 2025 04:25AM Savara (SVRA) PT Raised to $11 at Citizens on Molbreevi Demand Prospects
Sep 9, 2025 06:56AM
Sep 4, 2025 06:41AM
Sep 2, 2025 09:01AM
Aug 21, 2025 04:11AM
Aug 15, 2025 08:58AM
Aug 15, 2025 08:14AM
Aug 13, 2025 07:02PM Savara (SVRA) Misses Q2 EPS by 2c
Jun 5, 2025 11:58AM
Jun 2, 2025 08:58AM
May 29, 2025 06:07AM
May 28, 2025 07:09AM
May 28, 2025 07:07AM
May 27, 2025 08:06AM
May 13, 2025 04:19PM Savara (SVRA) Misses Q1 EPS by 2c
Apr 23, 2025 04:28AM
Apr 11, 2025 09:44AM
Apr 7, 2025 04:05PM
Mar 28, 2025 06:42AM
Mar 27, 2025 04:55AM
Mar 26, 2025 04:46PM
Mar 26, 2025 04:05PM Savara (SVRA) Completes Submission of the BLA for MOLBREEVI
Mar 6, 2025 08:07AM
Jan 30, 2025 08:39AM
Dec 18, 2024 04:07PM
Nov 13, 2024 06:54AM
Nov 13, 2024 06:09AM
Nov 12, 2024 08:10AM
Nov 12, 2024 08:10AM Savara (SVRA) Reports In-Line Q3 EPS
Oct 10, 2024 07:42AM

408,792 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All